Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial.

Michelle S CespedesMoupali DasJenna YagerMaria PrinsIvanka KrznaricJan de Jong Deqing XiaoYongwu ShaoPamela WongAlexander KintuChristoph CarterElske HoornenborgPeter RuaneJohn PhoenixIslam YounisJason Halperin

Published in: Transgender health (2024)

Clinicaltrials.gov registration number: NCT02842086.

Keyphrases

phase iii
men who have sex with men
hiv positive
antiretroviral therapy
hiv testing
hiv infected
human immunodeficiency virus
hepatitis c virus
study protocol
hiv aids
mental health
phase ii
randomized controlled trial
open label